NetworkNewsBreaks

FridayNov 16, 2018 10:42 am

NetworkNewsBreaks – CytoDyn Inc.’s (CYDY) PRO 140 HIV Monotherapy Trial Data Selected for Presentation at CROI 2019

Biotechnology company CytoDyn (OTCQB: CYDY) today announced that data from its ongoing investigative trial of PRO 140 (leronlimab) as a single subcutaneous therapy in HIV-1 infected patients was accepted for a poster presentation at next year’s Conference on Retroviruses and Opportunistic Infections (“CROI”).  Vice President, Clinical Operations at Amarex Clinical Research Dr. Kush Dhody will present the abstract, “PRO 140 SC: Long-acting, Single-agent Maintenance Therapy for HIV-1 Infection,” at CROI 2019, to be held in Seattle March 4-7, 2019. “We are highly encouraged by the recently reported data from our monotherapy trial for patients receiving once-weekly injections of PRO 140…

Continue Reading

FridayNov 16, 2018 10:37 am

NetworkNewsBreaks – Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) Eyes Israel to Forge Strong Relationships and Banking Initiatives for Medical Cannabis

Redfund Capital (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF), with today’s announcement that the medical cannabis bill will go to the Knesset agenda, has commented on the potential of Israel to allow the medical export of its products to global markets. Redfund is in the process of compiling final due diligence protocols surrounding several identified Israeli clients to become portfolio companies to execute its growth strategy into North America and Europe. “We are looking to Israel as our next country to forge strong relationships with for our banking initiatives,” Redfund CEO Meris Kott stated in the news release. “Israel has always…

Continue Reading

FridayNov 16, 2018 10:01 am

NetworkNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Presenting at the New Green Frontier Conference

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, today announced that the company’s president and CEO Andriyko Herchak will deliver a main stage company presentation at the invitation-only New Green Frontier cannabis investor conference. The conference, which is anticipated to be attended by more than 350 investors, will take place at The Arcadian Court in Toronto on Monday, November 19, 2018. “I am excited to have the opportunity to share our story and prospects for the future. We are committed to increasing our visibility in the investment community and the New Frontier…

Continue Reading

FridayNov 16, 2018 9:31 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses Plans for New Financing in Interview on MoneyTV

SinglePoint (OTCQB: SING) was a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program discussing “money and what makes it happen.” In this week’s episode, SinglePoint CEO Greg Lambrecht reiterated the company’s recent announcement that it has secured $5 million in financing from an existing institutional shareholder. “We spent a lot of time and money on becoming fully reporting, so we were able to renegotiate and get very favorable terms on the money we brought in. Of course, we're bringing this money in for acquisitions and to follow up on some…

Continue Reading

ThursdayNov 15, 2018 3:57 pm

NetworkNewsBreaks – Why Aziza Project is “One to Watch”

Aziza Project LLC is a fund that tokenizes high potential oil and gas businesses in Africa, empowering them to raise funds for profit and social good. A recent article discussing the company reads, “The vision for Aziza Project’s primary business is to light up Africa, bringing electricity to the 630 million people who currently have no access to the grid and typically depend on wood and paraffin for their energy needs, and in the process to deliver excellent returns to investors. … Through Aziza Coin, Aziza Project owns 20% of Africa New Energies (ANE), which holds rights to a 22,000-square-kilometer…

Continue Reading

ThursdayNov 15, 2018 3:27 pm

NetworkNewsBreaks – Medical Cannabis Payment Solutions (REFG) Positioned to Benefit as Legislators Predict Federal Cannabis Approval Bills in 2019

Medical Cannabis Payment Solutions (OTC: REFG) is poised to benefit if cannabis were to be legalized federally in the US. Two legislators believe that federal legalization bills will be passed in Congress in 2019. An article discussing the legislators’ predictions reads, “Reps. David Joyce (R-Ohio) and Earl Blumenauer (D-Oregon) told the session that bills legalizing cannabis in the U.S. – it has thus far been a state-by-state issue – would be introduced into Congress in 2019. They specifically cited the “STATES” Act (Strengthening the 10th Amendment through Entrusting States), introduced in June, which would exempt states with legal cannabis from…

Continue Reading

ThursdayNov 15, 2018 3:22 pm

NetworkNewsBreaks – Pacific Software, Inc. (PFSF) Connecting China and Latin America via E-commerce Trade Platform

Pacific Software (OTC: PFSF) is currently building a proprietary e-commerce trade platform with the potential to develop trade between Latin America and China. The platform is anticipated to be in production soon and will integrate blockchain components, including PFSF’s Agri-Blockchain. An article further discussing the company reads, “Development of the PFSF platform will be undertaken using IBM’s Hyperledger Blockchain “Backend as a Service” (BaaS) infrastructure. The IBM BaaS platform has the capability to record, store and track a variety of digital product information, such as farm origination details, batch numbers, factory and processing data, expiration dates, storage temperatures and shipping…

Continue Reading

ThursdayNov 15, 2018 2:29 pm

NetworkNewsBreaks – GreenBox POS, LLC (GRBX) Anticipates Rapid Processing Volume Growth

Hardware and software technology company GreenBox POS (OTC: GRBX) is aggressively adding strategic partners, growing its customer base and engaging new hires in preparation for upcoming growth. An article discussing the company reads, “The company recently announced that it had initiated a new banking relationship, as well as on-boarding and processing accounts volume of more than $50 million annually. GRBX has the option to boost the processing volume for these accounts alone to $100 million by the second quarter of 2019. GreenBox is also recruiting for careers at all levels in anticipation of the rapid processing volume growth (http://nnw.fm/SUEa5).” To…

Continue Reading

ThursdayNov 15, 2018 1:15 pm

NetworkNewsBreaks – Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF) Gears Up for Expected Lithium Shortage

As sales of electric vehicles (“EV”) continue to increase, a shortage of lithium seems imminent. Mineral explorer Lithium Chile (TSX.V: LITH) (OTCQB: LTMCF) is hoping to help bridge the gap. A recent article discussing the company reads, “As automakers ramp up production of EVs, supply shortages loom on the horizon. One large Tesla supplier expects (http://nnw.fm/3oLXT) a supply squeeze, “not in the short term, but in the longer term there is still risk of a shortage… especially 2023 and 2024…” Every tonne of lithium will count, and Lithium Chile is likely to have many to offer. The company now has a…

Continue Reading

ThursdayNov 15, 2018 1:09 pm

NetworkNewsBreaks – BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) Developing a Personalized Advanced Breast Cancer Treatment

BriaCell Therapeutics (OTC: BCTXF) (TSX.V: BCT), a biotechnology company developing targeted, safe treatments for cancer, is currently developing a personalized immunotherapy drug to treat advanced breast cancer. A recent article further discussing the company reads, “Based on its research results, the company is developing a second immunotherapy drug, Bria-OTS, an off-the-shelf personalized treatment that’s expected to be effective for 90 percent of the advanced breast cancer patient population. Bria-OTS is expected to go to clinical trials in 2019. … BriaCell Therapeutics Corp., based in Berkeley, California, and headquartered in Vancouver, British Columbia, is an immuno-oncology focused biotechnology company developing targeted…

Continue Reading